Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros












Base de datos
Intervalo de año de publicación
1.
ACS Chem Biol ; 15(11): 2958-2965, 2020 11 20.
Artículo en Inglés | MEDLINE | ID: mdl-33166443

RESUMEN

We designed and synthesized a novel Si-rhodamine derivative, NORD-1, as a red-light-controllable nitric oxide (NO) releaser, on the basis of photoredox parameter analysis. Red-light-responsive NO release from NORD-1 was confirmed by ESR spin trapping and quantified with an NO electrode and by means of Griess assay. The NO release cross section (ε656 nm·ΦNO) of NORD-1 was calculated to be 3.65 × 102, which is larger than that of a previously reported yellowish-green-light-controllable NO releaser, NO-Rosa5. The photoresponsiveness of NO release from NORD-1 was precise and efficient enough to induce vasodilation ex vivo under Magnus test conditions. Finally, we showed that intracavernous pressure (ICP) could be controlled in rats in vivo with the combination of NORD-1 and a red-light source without increasing systemic blood pressure, which is a serious side effect of usual NO releasers, such as nitroglycerin and isopentyl nitrite. NORD-1 is expected to be a useful chemical tool for NO research, as well as a candidate agent to control the circulatory system.


Asunto(s)
Relajación Muscular/efectos de los fármacos , Músculo Liso Vascular/efectos de los fármacos , Donantes de Óxido Nítrico/farmacología , Rodaminas/farmacología , Vasodilatación/efectos de los fármacos , Animales , Aorta/efectos de los fármacos , Aorta/fisiología , Células HEK293 , Humanos , Luz , Masculino , Músculo Liso Vascular/fisiología , Donantes de Óxido Nítrico/química , Ratas , Ratas Wistar , Rodaminas/química
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...